Dr. Joseph S. Gelbfish, MD

Dr. Gelbfish practices at New York-Presbyterian Hospital - Brooklyn HOPD in Brooklyn, New York.

Dr. Gelbfish's NPI, 1417058165, was assigned on September 26, 2006. Dr. Gelbfish graduated from New York University School of Medicine in 1980. Dr. Gelbfish's New York license number on file is 150961.

Dr. Gelbfish's primary practice is New York-Presbyterian Hospital - Brooklyn HOPD, at 506 Sixth Street, Brooklyn, NY 11215.

Dr. Gelbfish's primary practice is New York-Presbyterian Hospital - Brooklyn HOPD in Brooklyn, New York. Dr. Gelbfish is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Dr. Gelbfish to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gelbfish practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gelbfish's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Gelbfish is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Gelbfish has a license on file in New York.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, chronic hypertension and chronic skin ulcer among the conditions Dr. Gelbfish treats.

CMS data shows 4,738 Medicare services from Dr. Gelbfish across 22 procedure codes in 2024, for 328 Medicare patients. Medicare paid $235,046 for them.

CMS counts 328 Medicare patients who saw Dr. Gelbfish in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gelbfish's median patient age at 59, with 41% women.

In 2024, Dr. Gelbfish wrote 5,831 Medicare Part D claims for 324 patients. 81% of them were for generic drugs. CMS names the drug for 5,424 of them, across 75 drugs with 11 or more claims each, at $852,877 in total drug cost. In 2023, CMS named 5,119 claims across 64 drugs.

Dr. Gelbfish accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Gelbfish. The most frequent topics are Coronary Artery Bypass, Myocardial Infarction and Arterial Occlusive Diseases. Dr. Gelbfish's most frequent co-authors are Gerald Hollander, MD and Subbarao V. Mylavarapu, MD.

CMS Open Payments shows 299 general payments to Dr. Gelbfish from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $1,332.

Dmand AI lists 5 awards for Dr. Gelbfish, most recently Top Doctors: New York Metro Area in 2014.

Dr. Gelbfish graduated from New York University School of Medicine in 1980. Dr. Gelbfish is a member of ACC and ACP.

Dr. Gelbfish is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.